Connect with us

Health

AstraZeneca, Health Partners to Provide Equitable Cancer Care in Africa

Published

on

cancer care in africa

By Adedapo Adesanya

AstraZeneca and health partners have launched an initiative to transform outcomes for cancer patients across Africa.

Announced on the margins of the ongoing UN Climate Change Conference 2022, COP27, under the patronage of the Egyptian Ministry of Health, the Accelerating Change Together; Cancer Care in Africa (ACT; CCA) programme provides a platform for partners to co-create cancer care solutions that close the gaps in the existing patient care pathway, from diagnosis through to treatment and beyond.

At the inaugural event, government representatives, leading clinical and health experts, patient advocates, and private sector representatives signed the ACT; CCA Coalition Declaration to reaffirm their joint commitment to advancing equitable cancer outcomes for all Africans.

Speaking on this, Mr Pelin Incesu, Area Vice President for the Middle East and Africa, AstraZeneca, said – “While cancer treatment developments are moving quickly, equitable access to these innovations is not there for all. Our ambition is to nurture the cancer care ecosystem in Africa, bringing together local stakeholders to co-create solutions and encourage long-term investment that leads to equitable cancer outcomes.

“We need joint action to reverse the alarming increase in Africa’s cancer burden by addressing the unique barriers to cancer diagnosis and treatment, as well as building capacity that helps to make innovative care accessible to patients.”

Over 700,000 deaths occurred due to cancer across the region in 2020; across Sub-Saharan Africa, the current mortality rates are reaching 70 per cent in diagnosed cases. An estimated 2.1 million new cancer cases and 1.4 million deaths are expected annually by 2040 across the continent. Cancers of the breast and prostate are among the top three most prevalent.

ACT; CCA focuses on driving impact in lung, breast and prostate cancer through capacity building, early screening and diagnosis and patient empowerment. It is the regional chapter of the global Accelerating Change Together (ACT) for Cancer Care, an AstraZeneca-led effort to revolutionize the way cancer is diagnosed and treated to drive improvements in patient outcomes.

Over the next three years, ACT; CCA aims to drive screening and diagnostics covering one million people across cancer types and to provide training for more than 10,000 healthcare professionals across 100 oncology centres.

The programme is led by a steering committee of doctors, oncology institutions and advocacy groups to guide policy intervention, share learnings across borders, and put cancer patients at the centre. Members will meet on a regular basis to drive progress on cancer initiatives.

Adding his input, Dr Mohsen Mokhtar, Professor of Clinical Oncology and Managing Director of Cairo University Cancer Center, President of Can-Survive-Egypt, said collaboration was key to improving cancer outcomes.

“Each country joining the coalition invests heavily in cancer care programmes. We understand that by working together to develop a network that stretches beyond borders, we can close the gaps across the patient care pathway and provide solutions that improve outcomes and transform the patient journey not only for our own citizens but across the continent.”

Dr Mary Nyangasi, Head of the National Cancer Control Programme in Kenya, highlighted the disparity in care, saying, “In some areas, the lack of disease awareness, limited diagnostic capabilities, and an absence of structured programmes for early detection and access to treatment mean that equitable cancer care is not there for all. ACT; CCA is about levelling the playing field and collaborating to transform patient outcomes.”

It was revealed that launch events are planned over the coming months in Algeria, Morocco, and Kenya focused on local initiatives under the ACT; CCA umbrella.

Adedapo Adesanya is a journalist, polymath, and connoisseur of everything art. When he is not writing, he has his nose buried in one of the many books or articles he has bookmarked or simply listening to good music with a bottle of beer or wine. He supports the greatest club in the world, Manchester United F.C.

Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

SUNU Health Named Most Customer Focused HMO of the Year

Published

on

SUNU Health --logo

By Modupe Gbadeyanka

The decision of the management of SUNU Health Nigeria Limited to adopt the strategy of placing the enrollee and customer at the heart of its operations has started to pay off.

The company was recently announced as Most Customer-Focused Health Insurance Company of the Year at the Customer Service Standard Magazine Awards 2025.

The recognition underscored the company’s success in translating its dedication into tangible enrollee satisfaction and superior market service at the Nigerian Health Maintenance Organisation (HMO) landscape.

It also highlights the organisation’s dedicated efforts in streamlining claims processing, enhancing access to quality healthcare providers, and maintaining transparent, responsive communication channels with its diverse client base across Nigeria.

The accolade further serves as a powerful testament to the successful integration of digital solutions and human-centric service models at SUNU Health.

It positions the firm as a leader not only in providing robust health plans but also in delivering the supportive, personalized care that enrollees truly value.

“Clinching the Most Customer-Focused Health Insurance Company of the Year award is not just an honour; it is a validation of the core philosophy that drives every member of the SUNU Health team.

“We believe that healthcare is fundamentally a service industry, and our success is measured by the well-being and satisfaction of our enrollees,” the chief executive of SUNU Health, Mr Patrick Korie, commented.

“This award reinforces our resolve to continuously innovate and set new benchmarks for customer experience in the Nigerian health insurance sector.

“Our commitment to providing accessible, high-quality, and seamless healthcare solutions remains our top priority as we move into the new year (2026),” he added.

Continue Reading

Health

Nigeria Launches First National Antimicrobial Resistance Survey

Published

on

Antimicrobial Resistance Survey

By Adedapo Adesanya

Nigeria has launched its first nationally representative survey on antimicrobial resistance to generate critical data to guide evidence-based policies, improve patient outcomes, and strengthen health system resilience.

Antimicrobial resistance occurs when bacteria, viruses, fungi, and parasites evolve to resist treatment, making infections harder to cure.

As a result, surveillance is essential to track resistance patterns, identify priority pathogens, and guide targeted interventions and with support from the World Health Organization (WHO) and other partners, the initiative marks a milestone in the country’s public health response.

Nigeria becomes the third country globally to partner with WHO on a national antimicrobial resistance survey. having been selected based on the country’s strong commitment to AMR surveillance, its updated WHO Nigeria NAP 2.0, and readiness to expand laboratory and data systems.

Africa’s most populous country ranks 20th globally for age-standardized mortality due to antimicrobial resistance . In 2019, an estimated 263,400 deaths in Nigeria were linked to  it—more than the combined deaths from enteric infections, tuberculosis, respiratory infections, maternal and neonatal disorders, neglected tropical diseases, malaria, and cardiovascular diseases.

Globally, resistant infections in tertiary care settings cost between $2,371 and $29,289 per patient episode, extend hospital stays by an average of 7.4 days, and increase mortality risk by 84 per cent.

The survey will see the establishment of a national baseline on antimicrobial resistance prevalence to monitor interventions, assess the distribution, burden (morbidity, mortality, DALYs, cost), and diversity of AMR across regions and populations, as well as contribute to the global target of reducing AMR deaths by 10 per cent by 2030, in line with the political declaration endorsed at the 79th United Nations General Assembly in 2024.

It also seeks to strengthen routine antimicrobial resistance surveillance, including diagnostics, sample referral systems, and laboratory capacity.

Using WHO’s standardized methodology, the survey will run for 12–15 months and cover 40–45 randomly selected health facilities nationwide. Patients with suspected bloodstream infections (BSIs) will be identified using standard case definitions, and blood samples will be analysed in quality-assured laboratories.

Data will be collected across all age groups, covering clinical, demographic, laboratory, financial, and outcome indicators. Follow-up will occur at discharge, 28 days, and three months post-infection. The survey will sample approximately 35,000 patients suspected of BSIs to obtain around 800 isolates of the most common pathogens.

Dr Tochi Okwor, Acting Head, Disease Prevention and Health Promotion, Nigeria Centre for Disease Control and Prevention (NCDC) said, “With WHO’s support, we are confident the survey will generate the evidence needed to protect public health.”

WHO Representative in Nigeria, Dr Pavel Ursu, reaffirmed WHO’s commitment stating that ,“Nigeria is taking a decisive step toward combating AMR with an approach grounded in data, science, and measurable impact. This survey will provide the clarity needed to drive smarter policies, stronger surveillance, and better patient outcomes. Nigeria is laying the foundations for a resilient health system, one that protects lives, strengthens trust, and ensures that essential medicines remain effective for future generations.”

Adding her input, Dr Laetitia Gahimbare, Technical Officer at WHO Regional Office for Africa, added:“Strengthening surveillance enhances Nigeria’s capacity to detect and respond to AMR threats, supporting better patient outcomes, reinforcing health security, and building a resilient system.”

Professor Babatunde Ogunbosi, Paediatric Infectious Diseases Specialist at University College Hospital, Ibadan, highlighted the broader impact:, “This survey is about more than data. It’s about building national capacity for research, diagnostics, and policy. It integrates science into public health decision-making.”

Continue Reading

Health

Our Vision Extends Beyond Offering Health Insurance Packages—SUNU Health

Published

on

SUNU Health walk

By Modupe Gbadeyanka

One of the leading Health Maintenance Organisations (HMOs) in Nigeria, SUNU Health, has said its philosophy is proactive wellness, noting that this was why it recently partnered with The Divine Physician and St. Luke Catholic Chaplaincy Centre for a community health initiative.

The chief executive of the company, Dr Patrick Korie, said, “SUNU Health’s vision extends far beyond merely offering health packages and insurance.”

“We are fundamentally interested in proactive wellness—preventing illness rather than just treating it. This annual exercise is a crucial part of that commitment, and we will continue to champion it for as long as we exist,” he stressed.

The medical practitioner led the company’s annual Health Walk in Lagos on Saturday, November 8, 2025. The event drew hundreds of health enthusiasts, including the Chaplain of the centre, Rev Fr. John Okoria SJ.

His active participation reinforced the spiritual and moral commitment to holistic well-being, proving crucial in mobilizing staff and community members, thereby ensuring the vital wellness message reached a broad and deeply engaged audience.

The health walk covered several major streets in Lagos, starting from Ishaga Road and navigating through Itire Road, Randle Avenue, Akerele, Ogunlana Drive, and Workers Street before concluding back at the starting point. Following the vigorous walk, participants engaged in a session of high-energy aerobics and other outdoor exercises, reinforcing the day’s focus on fitness.

“We are delighted to champion this vital health initiative alongside the Catholic Chaplaincy Centre LUTH/CMUL. The turnout was truly delightful, reflecting the community’s deep desire to embrace wellness.

“Collaborations like this amplify our message and commitment to the Nigerian community,” the Brand and Corporate Communications Lead at SUNU Health, Mr Samuel Olayemi, stated.

Continue Reading

Trending